Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
MoonLake nanobody boosts ph. 3 endpoints in psoriatic arthritis
At week 16, 42.1% of patients achieved ACR50, and all secondary clinical endpoints were also met in the placebo-controlled study.
Marissa Russo
Aug 10, 2026 11:00am
Double shot of Vistagen’s anxiety nasal spray misses in ph. 2
Aug 6, 2026 10:32am
Altimmune GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 win
Jul 28, 2026 10:27am
MapLight shares sink on mixed ph. 2 schizophrenia readout
Jul 27, 2026 11:37am
Epicrispr gene silencer enhances muscle in muscular dystrophy
Jun 26, 2026 10:40am
Definium’s LSD depression drug produces ‘best ever’ ph. 3 data
Jun 22, 2026 7:00am
